Publication | Open Access

Optimization of pyrazole-containing 1,2,4-triazolo-[3,4-b]thiadiazines, a new class of STAT3 pathway inhibitors

Medicinal ChemistryBiochemistryMedicineNatural SciencesRational Drug DesignStat3 Pathway InhibitorsPharmacological AgentNew ClassPharmacotherapyDrug DevelopmentPharmacologyInhibitory ActivityDrug Discovery